Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Buzhong Tiaogan Formula (BTF) is a traditional Chinese medicine (TCM) herbal combination developed and used primarily for the prevention and treatment of colorectal cancer liver metastasis, particularly in patients with the "liver depression spleen deficiency" pattern as defined by TCM. The formula is being evaluated in clinical trials for its efficacy in delaying the occurrence of colorectal liver metastasis when used alongside standard antitumor therapies. Its mechanism of action, according to traditional theory, involves regulating Qi (vital energy), supporting spleen function, harmonizing liver function, and improving immune status. Modern research aims to assess its impact on quality of life, time to metastasis development, tumor microenvironment modulation, and immune state improvement[1]. The specific herbal composition may differ from classic formulas such as Bu Zhong Yi Qi Tang; however, it is based on similar principles—tonifying middle Jiao Qi (spleen/stomach), regulating Qi flow between the liver and spleen systems.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Buzhong Tiaogan Formula.